Latest filing published 01 Apr 2026 for 서울제약.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -21.1%Entry ₩2,710 · Close at T+90 ₩2,137
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
2018큐씨피13호사모투자: trading record in brief
2018큐씨피13호사모투자 is a declared insider of 서울제약, with filings sourced from DART (FSS). We count 2 filings; the first trade dates from 30 November 2022 and the latest from 26 March 2026.
Purchases make up the whole of the open-market record (2 purchases). The totals do not cover 2 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and no sales on the market.
On 1 April 2026 came the latest disclosure, an open-market purchase in 서울제약. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 2018큐씨피13호사모투자
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,291 sharesKRXDART:20260331004950Canonical exit: 24 Jun 2026 (T+90)
- 8,291 sharesKRXDART:20221130002033Canonical exit: 28 Feb 2023 (T+90)
2 of 2 declarations